This webinar is provided by National Jewish Health
This educational activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
The goal of this online program is to improve health care providers’ knowledge, competence and performance to close gaps related to early guideline-concordant diagnosis, management, and treatment of patients with Interstitial Lung Diseases (ILD) and Idiopathic Pulmonary Fibrosis (IPF). Topics included in the program are the natural history of IPF/ILD, early and accurate guideline-based diagnosis, differentiating IPF from other Interstitial Lung Diseases (ILD), and early initiation of treatment to improve patient outcomes.
Date and Time
This webinar will be held on three separate days
CME/CE credit provided